| Treatment of a first patient with FLASH-radiotherapy |
57 |
| Vulnerabilities of radiomic signature development: The need for safeguards |
44 |
| Clinical translation of FLASH radiotherapy: Why and how? |
43 |
| Clinical evaluation of atlas and deep learning based automatic contouring for lung cancer |
42 |
| X-rays can trigger the FLASH effect: Ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice |
42 |
| Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data |
40 |
| Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen |
39 |
| An integrated physico-chemical approach for explaining the differential impact of FLASH versus conventional dose rate irradiation on cancer and normal tissue responses |
38 |
| Biological effects in normal cells exposed to FLASH dose rate protons |
37 |
| ATR/CHK1 inhibitors and cancer therapy |
35 |
| Tracking tumor biology with radiomics: A systematic review utilizing a radiomics quality score |
34 |
| The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer |
32 |
| Reduced cognitive deficits after FLASH irradiation of whole mouse brain are associated with less hippocampal dendritic spine loss and neuroinflammation |
30 |
| Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: Multi-fraction treatment of pelvic lymph node oligometastases |
30 |
| Synthetic MRI-aided multi-organ segmentation on male pelvic CT using cycle consistent deep attention network |
28 |
| International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma |
28 |
| Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation? |
28 |
| Update of the systematic review of palliative radiation therapy fractionation for bone metastases |
26 |
| Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines |
26 |
| Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project |
26 |
| Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trial |
24 |
| Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies |
23 |
| Repeatability and reproducibility of MRI-based radiomic features in cervical cancer |
22 |
| Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy |
22 |
| Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review |
22 |
| Modifying a clinical linear accelerator for delivery of ultra-high dose rate irradiation |
21 |
| Nutritional counseling with or without systematic use of oral nutritional supplements in head and neck cancer patients undergoing radiotherapy |
21 |
| MRI commissioning of 1.5T MR-linac systems - a multi-institutional study |
21 |
| Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial |
20 |
| ESTRO ACROP: Technology for precision small animal radiotherapy research: Optimal use and challenges |
20 |
| PHASER: A platform for clinical translation of FLASH cancer radiotherapy |
20 |
| ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer |
19 |
| Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysis |
19 |
| GEC-ESTRO ACROP recommendations in skin brachytherapy |
19 |
| ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations |
19 |
| [Ga-68-]PSMA-11 PET/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard - Implications for focal radiotherapy planning in primary prostate cancer |
18 |
| Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042) |
18 |
| The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation |
18 |
| Feasibility of proton FLASH effect tested by zebrafish embryo irradiation |
18 |
| Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update |
18 |
| Confirmation of thermal dose as a predictor of local control in cervical carcinoma patients treated with state-of-the-art radiation therapy and hyperthermia |
17 |
| Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer |
17 |
| Radiobiology of Proton Therapy: Results of an international expert workshop |
17 |
| Toward A variable RBE for proton beam therapy |
16 |
| ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer |
16 |
| Cognitive impairment and morphological changes after radiation therapy in brain tumors: A review |
15 |
| Dosimetric and preparation procedures for irradiating biological models with pulsed electron beam at ultra-high dose-rate |
15 |
| MRI-only brain radiotherapy: Assessing the dosimetric accuracy of synthetic CT images generated using a deep learning approach |
15 |
| Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study |
15 |
| Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy |
15 |
